Mechanism of Action - The Beta Boost
Beta-agonists bind to β-adrenergic receptors, which are Gs-protein coupled. This binding initiates a signaling cascade, amplifying the initial signal.
- β1 (Heart): ↑ Inotropy, chronotropy, dromotropy, and renin release.
- β2 (Lungs/Vessels): Smooth muscle relaxation → bronchodilation & vasodilation.
⭐ Receptor location dictates the clinical effect: we have 1 heart (β1) and 2 lungs (β2).

The Agonist Lineup - Selectivity Spectrum
- Non-selective β-Agonists: Potent, but with widespread effects.
- Selective β-Agonists: Target specific receptor subtypes, minimizing off-target effects.
- β1-Selective Agonists (primarily cardiac)
- Dobutamine: ↑ Heart Rate, ↑ Contractility
- β2-Selective Agonists (primarily pulmonary/vascular smooth muscle)
- Albuterol, Salmeterol, Terbutaline: Bronchodilation
⭐ Dobutamine is a racemic mixture: the (+) isomer is a β1 agonist & α1 antagonist, while the (-) isomer is an α1 agonist. The net result is potent inotropy (β1) with minimal blood pressure change.
Clinical Applications - When to Beta-Test
- β1 Agonists (Dobutamine, Isoproterenol): Primarily for cardiac support.
- Cardiogenic Shock & Acute Decompensated HF: ↑ Inotropy & Heart Rate to boost cardiac output.
- Cardiac Stress Testing: Dobutamine mimics exercise by increasing myocardial O2 demand.
- β2 Agonists (Albuterol, Salmeterol, Terbutaline): For smooth muscle relaxation.
- Asthma/COPD: Albuterol (short-acting) for rescue; Salmeterol (long-acting) for maintenance.
- Tocolysis: Terbutaline relaxes the uterus to delay premature labor.
- Hyperkalemia: Drives K+ intracellularly, providing a temporary fix.
⭐ High-Yield: While effective for tocolysis, Terbutaline carries a Black Box Warning from the FDA against prolonged use (> 48-72 hours) due to risks of serious maternal heart problems and death.
Adverse Effects - The Beta Backfire

-
β1-Mediated (Cardiac):
- Tachycardia, palpitations, arrhythmias.
- Angina pectoris in patients with CAD (due to ↑ myocardial O₂ demand).
-
β2-Mediated (Systemic):
- Skeletal muscle tremor (most common).
- Hyperglycemia (↑ glycogenolysis).
- Hypokalemia (K⁺ driven into cells) → can worsen arrhythmias.
- Restlessness, anxiety.
⭐ Tachyphylaxis (tolerance) can develop with frequent use, particularly with Short-Acting Beta Agonists (SABAs), leading to ↓ therapeutic effect.
High‑Yield Points - ⚡ Biggest Takeaways
- Dobutamine (β1 > β2) is a key inotropic agent for acute heart failure and cardiogenic shock.
- Isoproterenol (non-selective β) causes potent increases in heart rate and contractility, but also significant vasodilation.
- Albuterol and Salmeterol (β2-selective) are primary bronchodilators for asthma/COPD; Salmeterol is long-acting.
- Terbutaline (β2-selective) is used for both bronchodilation and tocolysis (uterine relaxation).
- The core mechanism for all involves ↑ cAMP via Gs protein activation.
- Watch for tachycardia, tremor, and arrhythmias as key side effects.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more